Vasculearn Network
May 16, 2026, 16:04
How We Assess Coagulation in Patients on FXa Inhibitors and What May Come Next – Vasculearn Network
Vasculearn Network shared a post on X:
“New episode of Clot, Clot, Who’s There?
In urgent bleeding, PT/aPTT and anti-Xa are often the default.
But are they the right signal?
Our latest episode challenges how we assess coagulation in patients on FXa inhibitors, and what may come next.”
Stay updated with Hemostasis Today.
-
May 16, 2026, 16:07Pathophysiology of Impaired Hemostasis in GT – Glanzmann’s Research Foundation
-
May 16, 2026, 16:05Ifeanyichukwu Ifechidere: The Overlooked Diagnosis of VWD in Young Girls With Menorrhagia
-
May 16, 2026, 16:04Paulus Kirchhof: Atrial Fibrillation Burden and Stroke Risk in Patients With Implanted Devices
-
May 16, 2026, 16:02ASTRO-Kids Global Survey Calls for International Guidance On Postthrombotic Care in Children – JTH
-
May 16, 2026, 15:56Luma Mahairi: Social Determinants of Health Across Hematology Shaping The Outcomes
-
May 16, 2026, 15:50How Confident Are You in Hematology Basics? – ASH
-
May 16, 2026, 15:41Jules Mercier-Ross: A Narrative Review of Acute Chest Syndrome in Pediatric Patients with SCD
-
May 16, 2026, 15:14Asesa Omullo: Living Stronger With Sickle Cell Through RBC Exchange Therapy
-
May 16, 2026, 14:58Nathan Connell: The Changing Landscape of von Willebrand Disease Diagnosis and Management